Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

33.03
Delayed Data
As of Dec 09
 +0.19 / +0.58%
Today’s Change
20.39
Today|||52-Week Range
35.06
+0.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues32.1M47.7M160.9M88.3M
 
 
 
 
 
Depreciation And Amortization221.0K352.0K639.0K--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses22.8M28.4M36.1M57.4M
 
 
 
 
 
Research And Development16.8M18.7M23.2M40.5M
 
 
 
 
 
Total Operating Expenses23.0M28.8M36.7M57.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income9.0M19.0M124.1M30.8M
 
 
 
 
 
Extraordinary Credit----347.0K--
 
 
Extraordinary Charge---166.0K0.00--
 
 
Interest Expense On Debt31.0K18.0K8.0K--
 
 
 
 
Other Expenses381.0K0.000.001.7M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income9.6M19.3M125.5M32.6M
 
 
 
 
 
Income Taxes0.00-15.2M-46.5M-10.9M
 
 
 
 
Preferred Dividend-2.5M0.000.00--
 
 
Net Income-4.0M34.4M79.0M21.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.8M18.4M18.7M18.9M
 
 
 
 
 
Shares To Calculate EPS Diluted9.8M19.2M19.3M19.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.67$1.80$4.09$1.13
 
 
 
 
 
EPS Diluted-$0.67$1.80$4.09$1.13